Regulatory Revisions, Cut Backs At Big Pharma, Provide Spark For China Innovation - BayHelix Annual Meeting

SHANGHAI - BayHelix, a leading life sciences professional society for business leaders of Chinese origin, held its eighth annual conference in Shanghai April 10, and the day-long symposium trumpeted the opportunities for domestic pharma innovation brought on by China's healthcare reform and regulatory enhancements

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip